Clearance Summary
REAADS IGG ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KIT received FDA 510(k) clearance under submission number K001352, sponsored by Corgenix, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2001-04-09.
- Submission: K001352
- Applicant / Sponsor: Corgenix, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5820
- Decision date: 2001-04-09
Classification & Regulation
This clearance is catalogued under FDA product code DHC and 21 CFR 866.5820, within the Immunology review panel as a Class II device.